These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes. Mulder TB; Grol CJ; Dijkstra D; Horn AS Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139 [TBL] [Abstract][Full Text] [Related]
29. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. Kula NS; Baldessarini RJ; Bromley S; Neumeyer JL Life Sci; 1985 Sep; 37(11):1051-7. PubMed ID: 4033350 [TBL] [Abstract][Full Text] [Related]
30. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner. Nakajima T; Iwata K Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457 [TBL] [Abstract][Full Text] [Related]
31. Age alters dopaminergic responses to estradiol. Roy EJ; Sheinkop S; Wilson MA Eur J Pharmacol; 1982 Aug; 82(1-2):73-5. PubMed ID: 6889971 [TBL] [Abstract][Full Text] [Related]
32. Aging process affects a single class of dopamine receptors. Memo M; Lucchi L; Spano PF; Trabucchi M Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912 [TBL] [Abstract][Full Text] [Related]
33. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN. Buczko W; De Blasi A Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186 [TBL] [Abstract][Full Text] [Related]
34. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. MacKenzie RG; Zigmond MJ J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330 [TBL] [Abstract][Full Text] [Related]
35. The effects of a long term dihydroergotoxine treatment on agonist and antagonist striatal dopamine binding sites are dose and age related. Ferretti C; Blengio M; Eva C; Ghi P; Bosco MC; Portaleone P Pharmacol Res Commun; 1986 Oct; 18(10):967-78. PubMed ID: 3809237 [TBL] [Abstract][Full Text] [Related]
36. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. Leff SE; Creese I Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067 [TBL] [Abstract][Full Text] [Related]
37. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. List SJ; Seeman P Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314 [TBL] [Abstract][Full Text] [Related]
38. Dopamine receptors in the striatum and limbic system of various strains of mice: relation to differences in responses to apomorphine. Michaluk J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Sansone M; Oliverio A; Vetulani J Pharmacol Biochem Behav; 1982 Dec; 17(6):1115-8. PubMed ID: 6891791 [TBL] [Abstract][Full Text] [Related]
39. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine. Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice. Thermos K; Winkler JD; Weiss B Neuropharmacology; 1987 Oct; 26(10):1473-80. PubMed ID: 3120028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]